Instil Bio (TIL) Non-Current Deferred Tax Liability (2020 - 2022)
Instil Bio (TIL) posted quarterly Non-Current Deferred Tax Liability of $555000.0 for Q3 2022, down 62.37% year-over-year from $1.5 million in Q3 2021, and down 48.9% quarter-over-quarter from $1.1 million in Q2 2022.
Instil Bio (TIL) Non-Current Deferred Tax Liability (2020 - 2022) Analysis & Trends
Instil Bio's Non-Current Deferred Tax Liability history runs 3 years deep, the most recent figure standing at $555000.0 for Q3 2022.
- In Q3 2022, Non-Current Deferred Tax Liability fell 62.37% year-over-year to $555000.0; the TTM figure through Sep 2022 stood at $555000.0 (down 62.37% YoY), while the FY2021 annual figure was $2.4 million, down 13.85% from the prior year.
- Non-Current Deferred Tax Liability for Q3 2022 stood at $555000.0, down from $1.1 million in the prior quarter.
- The five-year high for Non-Current Deferred Tax Liability was $2.8 million in Q4 2020, with the low at $555000.0 in Q3 2022.
- The 3-year median for Non-Current Deferred Tax Liability is $2.0 million (2021), against an average of $1.8 million.
- The sharpest annual moves came in 2021 and 2022: Non-Current Deferred Tax Liability declined 13.85% in 2021, then tumbled 62.37% in 2022.
- Instil Bio's Non-Current Deferred Tax Liability stood at $2.8 million in 2020, then slipped by 13.85% to $2.4 million in 2021, then tumbled by 77.12% to $555000.0 in 2022.
- Business Quant data shows TIL's Non-Current Deferred Tax Liability at $555000.0 in Q3 2022, $1.1 million in Q2 2022, and $1.9 million in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Instil Bio | 50.29 Mn | 50.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 1.51 Mn |
| Dec 31, 2022 | 1.51 Mn |
| Sep 30, 2022 | 555,000.00 |
| Sep 30, 2022 | 555,000.00 |
| Jun 30, 2022 | 1.09 Mn |
| Jun 30, 2022 | 1.09 Mn |
| Mar 31, 2022 | 1.95 Mn |
| Mar 31, 2022 | 1.95 Mn |
| Dec 31, 2021 | 2.43 Mn |
| Dec 31, 2021 | 2.43 Mn |
| Sep 30, 2021 | 1.48 Mn |
| Sep 30, 2021 | 1.48 Mn |
| Jun 30, 2021 | 2.11 Mn |
| Jun 30, 2021 | 2.11 Mn |
| Mar 31, 2021 | 2.27 Mn |
| Mar 31, 2021 | 2.27 Mn |
| Dec 31, 2020 | 2.82 Mn |
| Dec 31, 2020 | 2.82 Mn |